肝癌合并门静脉癌栓外科治疗进展及策略  

Progress and strategies of surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus

作　　者：杜成旭 李冬瑞[1] 张树彬[1] 边伟[1] 刘建华[1] Du Chengxu;Li Dongrui;Zhang Shubin;Bian Wei;Liu Jianhua(Department of Hepatobiliary and Pancreatic Surgery,Second Hospital of Hebei Medical University,Shijiazhuang 050000,China)

机构地区：[1]河北医科大学第二医院肝胆胰外科,石家庄050000

出　　处：《中华消化外科杂志》2023年第2期214-218,共5页Chinese Journal of Digestive Surgery

基　　金：河北省自然科学基金(H2022206284);河北省医学适用跟踪项目(GZ2021032);河北省2022年政府资助临床医学优秀人才培养项目(303-2022-27-17)。

摘　　要：肝癌合并门静脉癌栓(PVTT)发病率高、预后不佳,其治疗模式逐渐向多学科综合治疗模式转变。笔者从肝癌合并PVTT的发生基础、分型,手术治疗指征、术后辅助治疗和术前转化治疗方案等内容进行深入分析,旨在为该病的诊断与治疗提供参考。The incidence of portal vein tumor thrombus(PVTT)in patients with hepato-cellular carcinoma(HCC)is high and the prognosis is poor.The treatment mode of HCC+PVTT is changing to multidisciplinary comprehensive treatment.The authors make a deep investigation on the occurrence basis,classification,surgical treatment indication,postoperative adjuvant treatment and preoperative conversion treatment plan of HCC+PVTT,in order to provide reference for the diagnosis and treatment of this disease.

关 键 词：肝肿瘤 晚期肝癌 门静脉癌栓 手术治疗 综合治疗 

分 类 号：R735.7[医药卫生—肿瘤]